EMC
53
-3
MRK
37
5
AMT
45
-7
GWW
39
-2
MAT
43
-4
MAR
30
-2
HAL
44
-2
MTCH
44
-4
CL
62
-2
CMI
38
-16
PAYX
42
-2
MCD
55
-4
CLX
66
-2
EXR
40
5
HD
38
-5
FLS
50
-2
BDX
47
-4
DRI
60
-7
PCAR
42
-7
MAC
37
-2
EMC
53
-3
MRK
37
5
AMT
45
-7
GWW
39
-2
MAT
43
-4
MAR
30
-2
HAL
44
-2
MTCH
44
-4
CL
62
-2
CMI
38
-16
PAYX
42
-2
MCD
55
-4
CLX
66
-2
EXR
40
5
HD
38
-5
FLS
50
-2
BDX
47
-4
DRI
60
-7
PCAR
42
-7
MAC
37
-2
Financhill
Back

Dorman Products Vs. Monopar Therapeutics Industry Stock Comparison

Buy
58

DORM
Dorman Products

Last Price:
$125.26
Seasonality Move:
7.6%
Sell
29

MNPR
Monopar Therapeutics

Last Price:
$30.03
Seasonality Move:
-28.14%
Buy
58
Dorman Products (DORM) is a Buy

Is Dorman Products a Buy, Sell or Hold?

  • The current Dorman Products [DORM] share price is $125.29. The Score for DORM is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • DORM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
29
Monopar Therapeutics (MNPR) is a Sell

Is Monopar Therapeutics a Buy, Sell or Hold?

  • The current Monopar Therapeutics [MNPR] share price is $29.49. The Score for MNPR is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DORM Stock Price Chart

What is Dorman Products's stock price today?

  • The Dorman Products share price today is $125.29
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DORM is experiencing selling pressure, which indicates risk of future bearish movement.

MNPR Stock Price Chart

What is Monopar Therapeutics's stock price today?

  • The Monopar Therapeutics share price today is $29.49
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing selling pressure, which indicates risk of future bearish movement.

DORM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.49 Sell
Relative Strength Index (14 RSI): 44.76 Sell
Chaikin Money Flow: -193045 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (124.83 - 130.35) Sell
Bollinger Bands (100): (122.52 - 137.16) Sell

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.49 Sell
Relative Strength Index (14 RSI): 40.75 Sell
Chaikin Money Flow: -33280 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (30.71 - 47.25) Sell
Bollinger Bands (100): (15.34 - 38.02) Buy

DORM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 128.59 Sell
20-day SMA: 127.24 Sell
50-day SMA: 128.56 Sell
200-day SMA: 115.89 Buy
8-day EMA: 127.32 Sell
20-day EMA: 127.87 Sell
50-day EMA: 128.55 Sell
200-day EMA: 117.94 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 30.32 Sell
20-day SMA: 36.52 Sell
50-day SMA: 34.82 Sell
200-day SMA: 15.16 Buy
8-day EMA: 30.92 Sell
20-day EMA: 34.18 Sell
50-day EMA: 33.46 Sell
200-day EMA: 19.84 Buy

Dorman Products Earnings Growth & DORM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.56 per share, a decrease next quarter of $0.49 per share, an increase this year of $0.79 per share, and an increase next year of $0.66 per share.

Monopar Therapeutics Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.

Dorman Products Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):